Table of Contents As filed with the Securities and Exchange Commission on March 10, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPA ...

Financial Reporting - GSK filed its Annual Report on Form 20-F for the year ended December 31, 2022, on March 10, 2023[4] - The report includes audited financial statements, which are available online at GSK's website and the SEC's website[4] - Shareholders can request a hard copy of the complete audited financial statements free of charge[5] Forward-Looking Statements - GSK cautions that forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially[7]

GSK plc (NYSE:GSK) Q4 2022 Earnings Conference Call February 1, 2023 6:00 AM ET Company Participants Nick Stone - Head, Global Investor Relations Emma Walmsley - CEO & Director Tony Wood - Chief Scientific Officer Luke Miels - Chief Commercial Officer Deborah Waterhouse - Chief Executive Officer, ViiV Healthcare & President, Global Health Iain Mackay - CFO & Executive Director Conference Call Participants Kerry Holford - Berenberg Peter Welford - Jefferies Dominic Lunn - Crédit Suisse Timothy Anderson - Wol ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-15170 GSK plc (Translation of registrant's name into English) 980 Great West Road, Brentford, Middlesex, TW8 9GS (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or For ...

GSK plc (NYSE:GSK) 41st Annual JPMorgan Healthcare Conference January 10, 2023 10:30 AM ET Company Participants Emma Walmsley - Chief Executive Officer Luke Miels - Chief Commercial Officer David Redfern - President Corporate Development Tony Wood - Chief Scientific Officer Deborah Waterhouse - CEO of ViiV, HIV business Iain MacKay - Chief Financial Officer Conference Call Participants James Gordon - JPMorgan James Gordon Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And toda ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ Issued: Wednesday, 2 November 2022, London U.K. For the month of ...

27 July 2022 Half year and Q2 2022 Results Conference call and webcast for investors and analysts gsk.com Cautionary statement regarding forward-looking statements This presentation may contain forward-looking statements. Forward-looking statements give the Group's current expectations or forecasts of future events. An investor can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as 'anticipate', 'estimate', 'expect', 'intend', 'will' ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number 001-15170 GSK plc (Translation of registrant's name into English) 980 Great West Road, Brentford, Middlesex, TW8 9GS (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40 ...

GlaxoSmithKline plc (NYSE:GSK) UBS Global Healthcare Conference Call May 24, 2022 9:15 AM ET Company Participants Kimberly Smith - Head of Global Research & Medical Strategy Conference Call Participants Laura Sutcliffe - UBS Laura Sutcliffe All right. Good morning, everyone. Welcome back to day two of the UBS Global Healthcare Conference. My name is Laura Sutcliffe, I am a pharmaceuticals analyst here at UBS. And it's my great pleasure to have with me this morning, Dr. Kimberly Smith, who is the Head of R&D ...

GlaxoSmithKline plc (NYSE:GSK) Q1 2022 Results Conference Call April 27, 2022 7:00 AM ET Company Participants Nick Stone - Head of Global Investor Relations Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Deborah Waterhouse - Chief Executive Officer, ViiV Healthcare Brian McNamara - Chief Executive Officer, GSK Consumer Health Luke Miels - Chief Commercial Officer Roger Connor - President, Vaccine and Global Health Hal Barron - Chief Scientific Officer Conference Call Participa ...